会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • NEW POLYPEPTIDES HAVING AFFINITY FOR HER2
    • 具有HER2感染力的新型多肽
    • WO2009080810A1
    • 2009-07-02
    • PCT/EP2008/068167
    • 2008-12-22
    • AFFIBODY ABABRAHMSÉN, LarsHERNE, NinaFELDWISCH, JoachimLENDEL, ChristoferTOLMACHEV, Vladimir
    • ABRAHMSÉN, LarsHERNE, NinaFELDWISCH, JoachimLENDEL, ChristoferTOLMACHEV, Vladimir
    • C07K14/31C07K14/485A61K38/18A61K51/08A61P35/00G01N33/68
    • A61K51/08A61K38/00A61K51/088C07K16/32
    • HER2 binding polypeptides comprising the amino acid sequence EX 1 RNAYWEIA LLPNLTNQQK RAFIRKLYDD PSQSSELLX 2 E AKKLNDSQ wherein X 1 in position 2 is M, I or L, and X 2 in position 39 is S or C (SEQ ID NO:1 ) are disclosed. Moreover, such peptides comprising a chelating environment are disclosed. Also radiolabeled polypeptides formed by the peptides comprising a chelating environment and radionuclides are disclosed. Furthermore, methods of in vivo imaging of the body of a mammalian subject having or suspected of having a cancer characterized by overexpression of HER2 comprising administration of such a radiolabeled polypeptide followed by obtainment of an image of the body using a medical imaging instrument and also methods of treating such cancer are disclosed. Furthermore, the use of such a radiolabeled polypeptide in diagnosis and treatment of cancer characterized by overexpression of HER2. Nucleic acids encoding the polypeptides, expression vectors comprising the nucleic acids and host cells comprising the expression vectors are also disclosed.
    • HER2结合多肽包含氨基酸序列EX1 RNAYWEIA LLPNLTNQQK RAFIRKLYDD PSQSSELLX2E AKKLNDSQ,其中位置2中的X1是M,I或L,而位置39的X2是S或C(SEQ ID NO:1)。 此外,公开了包含螯合环境的这些肽。 还公开了由包含螯合环境和放射性核素的肽形成的放射性标记的多肽。 此外,具有或怀疑具有HER2过表达的哺乳动物受试者的身体的体内成像方法包括施用这种放射性标记的多肽,然后使用医学成像仪获得身体的图像,以及方法 公开了治疗这种癌症的方法。 此外,这种放射性标记的多肽在诊断和治疗HER2过表达的癌症中的应用。 还公开了编码多肽的核酸,包含核酸的表达载体和包含表达载体的宿主细胞。
    • 2. 发明申请
    • POLYPEPTIDE LIBRARIES WITH A PREDETERMINED SCAFFOLD
    • 具有预测SCAFFOLD的多肽图书馆
    • WO2009080811A1
    • 2009-07-02
    • PCT/EP2008/068168
    • 2008-12-22
    • AFFIBODY ABABRAHMSÉN, LarsHERNE, NinaLENDEL, ChristoferFELDWISCH, Joachim
    • ABRAHMSÉN, LarsHERNE, NinaLENDEL, ChristoferFELDWISCH, Joachim
    • C07K1/04C12N15/10G01N33/68C12Q1/68
    • C07K14/31C07K1/047C12N15/1037C12N15/1041C12N15/1044C12N15/1075C40B40/10G01N33/6845G01N2333/31
    • Populations of polypeptide variants based on a common scaffold, each polypeptide in the population comprising the scaffold amino acid sequence EXXXAXXEIX XLPNLTXXQX XAFIXKLXDD PSQSSELLSE AKKLNDSQ or AKYAKEXXXAXX EIXXLPNLTX XQXXAFIXKL XDDPSQSSEL LSEAKKLNDS Q, wherein each X individually corresponds to an amino acid residue which is varied in the population are disclosed. Also populations of polynucleotides, wherein each member encodes a member of a polypeptide population are disclosed. Furthermore, combinations of such polypeptide populations and such polynucleotide populations are disclosed, wherein each member of polypeptide population is physically or spatially associated with the polynucleotide encoding that member via means for genotype-phenotype coupling. Furthermore, methods for selecting a desired polypeptide having an affinity for a predetermined target from a population of polypeptides, isolation of a polynucleotide encoding a desired polypeptide having an affinity for a predetermined target, identifying a desired polypeptide having an affinity for a predetermined target, selecting and identifying a desired polypeptide having affinity for a predetermined target, and production of a desired polypeptide having an affinity for a predetermined target are disclosed.
    • 基于常见支架的多肽变体群体,群体中的每个多肽包含支架氨基酸序列EXXXAXXEIX XLPNLTXXQX XAFIXKLXDD PSQSSELLSE AKKLNDSQ或AKYAKEXXXAXX EIXXLPNLTX XQXXAFIXKL XDDPSQSSEL LSEAKKLNDS Q,其中每个X分别对应于在群体中变化的氨基酸残基 被披露。 还公开了多核苷酸的种群,其中每个成员编码多肽群体的成员。 此外,公开了这样的多肽群体和这种多核苷酸群体的组合,其中多肽群体的每个成员通过用于基因型 - 表型偶联的方法与编码该成员的多核苷酸物理或空间相关联。 此外,从多肽群体中选择对预定靶标具有亲和性的期望多肽的方法,分离编码对预定靶标具有亲和性的期望多肽的多核苷酸,鉴定对预定靶标具有亲和性的期望多肽,选择 并鉴定对预定靶标具有亲和力的所需多肽,以及对预定靶标具有亲和性的所需多肽的制备。
    • 6. 发明申请
    • CONJUGATES OF ALBUMIN BINDING DOMAIN
    • ALBUMIN绑定域的结合
    • WO2010054699A1
    • 2010-05-20
    • PCT/EP2008/065691
    • 2008-11-17
    • AFFIBODY ABABRAHMSÉN, LarsEKBLAD, Caroline
    • ABRAHMSÉN, LarsEKBLAD, Caroline
    • A61K47/48
    • B82Y5/00A61K47/643A61K47/66
    • The invention provides a capture molecule for modulation of pharmacokinetics (PK) and/or pharmacodynamics (PD) of a target having a biological function in a mammal, comprising i) at least one target binding moiety capable of interacting with a target, said interaction being characterized by a first K0 value; ii) at least one albumin binding moiety capable of binding to albumin, said binding being characterized by a second K0 value; wherein said interaction with a target at a pH value of 5.5 modulates PK and/or PD of said target in said mammal. Also provided are methods and uses of a capture molecule for the treatment of a mammal by PK/PD modulation of a target molecule.
    • 本发明提供了用于调节哺乳动物具有生物功能的靶的药代动力学(PK)和/或药效学(PD)的捕获分子,其包含i)至少一个能够与靶相互作用的靶结合部分,所述相互作用为 其特征在于第一K0值; ii)至少一种能够结合白蛋白的白蛋白结合部分,所述结合的特征在于第二K0值; 其中所述与pH值为5.5的靶的相互作用调节所述哺乳动物中所述靶的PK和/或PD。 还提供了捕获分子用于通过靶分子的PK / PD调节来治疗哺乳动物的方法和用途。